HM Capital Management’s Merck MRK Stock Holding History

HM Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$227K	Buy	2,634 +6	+0.2%	+$536	0.14%	50
2022 Q2	$240K	Buy	2,628 +6	+0.2%	+$532	0.13%	52
2022 Q1	$215K	Sell	2,622 -125	-5%	-$9.86K	0.08%	58
2021 Q4	$211K	Buy	2,747 +6	+0.2%	+$478	0.08%	56
2021 Q3	$206K	Sell	2,741 -289	-10%	-$22K	0.09%	42
2021 Q2	$236K	Sell	3,030 -449	-13%	-$33.4K	0.1%	41
2021 Q1	$256K	Buy	3,479 +6	+0.2%	+$443	0.12%	39
2020 Q4	$271K	Sell	3,473 -480	-12%	-$36.7K	0.14%	33
2020 Q3	$313K	Buy	3,953 +6	+0.2%	+$470	0.19%	26
2020 Q2	$291K	Buy	3,947 +5	+0.1%	+$376	0.19%	25
2020 Q1	$289K	Buy	3,942 +13	+0.3%	+$1.02K	0.21%	28
2019 Q4	$341K	Buy	3,929 +59	+2%	+$4.85K	0.21%	32
2019 Q3	$311K	Buy	3,870 +11	+0.3%	+$882	0.2%	32
2019 Q2	$309K	Buy	3,859 +13	+0.3%	+$995	0.19%	33
2019 Q1	$305K	Buy	3,846 +12	+0.3%	+$898	0.22%	28
2018 Q4	$280K	Buy	3,834 +13	+0.3%	+$918	0.24%	31
2018 Q3	$259K	Buy	3,821 +14	+0.4%	+$892	0.2%	34
2018 Q2	$221K	Sell	3,807 -42	-1%	-$2.37K	0.17%	37
2018 Q1	$200K	Sell	3,849 -198	-5%	-$10.7K	0.16%	41
2017 Q4	$217K	Sell	4,047 -20	-0.5%	-$1.11K	0.18%	38
2017 Q3	$249K	Buy	4,067 +58	+1%	+$3.52K	0.22%	34
2017 Q2	$245K	Buy	4,009 +96	+2%	+$5.84K	0.23%	36
2017 Q1	$236K	Buy	3,913 +15	+0.4%	+$910	0.23%	34
2016 Q4	$219K	Buy	3,898 +55	+1%	+$3.22K	0.22%	35
2016 Q3	$230K	Buy	+3,843	New	+$225K	0.23%	35

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HM Capital Management's MRK Position: Q3 2022 in Review

HM Capital Management increased its Merck (MRK) stake by 0.23% in Q3 2022, buying an estimated $536 and bringing the position to 2,634 shares worth $227K. The position accounts for 0.14% of the portfolio, ranked #50.

HM Capital Management first reported a position in MRK in Q3 2016 and has held it in 25 quarters since. The position peaked at $341K in Q4 2019. 2,992 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

HM Capital Management held 2,634 shares of Merck worth $227K as of Q3 2022.
HM Capital Management bought 6 Merck shares in Q3 2022, an estimated $536.
Merck made up 0.14% of HM Capital Management's portfolio in Q3 2022, its #50 holding.
HM Capital Management first reported a position in Merck in Q3 2016 and has held it in 25 quarters since.
HM Capital Management's Merck position peaked at $341K in Q4 2019.
2,992 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on HM Capital Management's 13F filing for Q3 2022, filed 7 Nov 2022.